New York Valves 2025 - Dr Sunny Goel (Mount Sinai Hospital, New York, US) joins us to discuss the current devices and strategies that are used for embolic protection and stroke prevention in transcatheter aortic valve replacement (TAVR). Dr Goel highlights the lack of strong guidelines in the field and shares findings from recent studies investigating embolic protection devices.

Interview Questions:
1. Which patient populations are at the highest risk for embolic events during TAVR?
2. What strategies are currently used to minimise stroke risk during TAVR, and what are the current unmet needs?
3. How do current guidelines or consensus statements address the use of embolic protection devices (EPDs) in TAVR?
4. Have the results of recent clinical trials influenced your practice?
5. What advice would you give to cardiologists about incorporating embolic protection into TAVR practice?
6. Are there emerging technologies or techniques that might improve embolic protection during TAVR?

Recorded remotely from New York, 2025.

Editors: Yazmin Sadik, Jordan Rance
Videographer: David Ben-Harosh

Support: This is an independent interview produced by Radcliffe Cardiology.